Publication: Diagnostic accuracy of nucleic acid amplification-based assays for clostridium perfringens-associated diseases: A systematic review and meta-analysis
Issued Date
2020-09-01
Resource Type
ISSN
1098660X
00951137
00951137
Other identifier(s)
2-s2.0-85089922201
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Microbiology. Vol.58, No.9 (2020)
Suggested Citation
Ke Chen, Sarfraz Ahmed, Yun Juan Sheng, Changfeng Sun, Cun Liang Deng, Suvash Chandra Ojha Diagnostic accuracy of nucleic acid amplification-based assays for clostridium perfringens-associated diseases: A systematic review and meta-analysis. Journal of Clinical Microbiology. Vol.58, No.9 (2020). doi:10.1128/JCM.00363-20 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/59180
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Diagnostic accuracy of nucleic acid amplification-based assays for clostridium perfringens-associated diseases: A systematic review and meta-analysis
Abstract
© 2020 American Society for Microbiology. Timely and accurate methods for detecting Clostridium perfringensassociated diseases (CPAD) are crucial to improve patient care. A number of studies have evaluated the accuracy of nucleic acid amplification tests (NAAT) in detecting CPAD, but decisive results about their effectiveness have not been reported. We conducted a meta-analysis to evaluate the diagnostic performance of NAAT for detecting C. perfringens in clinical diarrheal samples. Five databases including PubMed, Embase, Scopus, Web of Science, and the Cochrane library were systematically probed for studies published before 6 December 2019. From 2,632 citations, we identified five eligible studies comprising 817 samples. Three studies (n =695 samples) compared NAAT with a microbiological culture while the other three studies (n =322 samples) compared NAAT with an immunoassay. NAAT revealed higher diagnostic accuracy against immunoassay (sensitivity, 0.53 [95% confidence interval [CI], 0.35 to 0.7]; specificity, 0.97 [95% CI, 0.95 to 0.99]; positive likelihood ratio [PLR], 23.2 [95% CI, 3.49 to 153.98]; negative likelihood ratio [NLR], 0.25 [95% CI, 0 to 245.28]; diagnostic odds ratio [DOR], 74.11 [95% CI, 2.11 to 2,593.7]) than microbiological culture (sensitivity, 0.31 [95% CI, 0.22 to 0.41]; specificity, 0.95 [95% CI, 0.93 to 0.97]; PLR, 11.56 [95% CI, 3.87 to 34.6]; NLR, 0.57 [95% CI, 0.27 to 1.21]; DOR, 18.1 [95% CI, 4.83 to 67.8]). NAAT pooled specificity was consistently ^ge;95% against that of applied reference standards. A meta-regression and subgroup analysis of sample condition, gene target, study design, and reference standards could not explain the heterogeneity (P > 0.05) in the diagnostic efficiency. The analysis has demonstrated that the diagnostic accuracy of NAAT is relatively insufficient to replace traditional reference standards as a single diagnostic test. NAAT can be applied in combination with microbiological culture because of the advantage of time to result and in scenarios where traditional tests are not feasible. Further investigations in this direction with larger sample sizes are still warranted to support our findings.